Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01976819
Other study ID # UD788_TW
Secondary ID
Status Completed
Phase N/A
First received October 17, 2013
Last updated August 10, 2017
Start date October 2013
Est. completion date April 2014

Study information

Verified date August 2017
Source Atos Medical AB
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical investigation addresses the performance of a re-designed The current study aims to investigate the next version of the TW speaking valve, in combination with both a 15mm and 22mm HME cassette.


Description:

This clinical investigation addresses the performance of a re-designed (updated) speaking valve with Heat and Moisture Exchangers (HME) for tracheotomized patients (project development name 'TW', commercial name 'DualCare'). Study participants trial the new device for 2 weeks after which they can choose to discontinue using the device or continue in the 3 month follow-up part of the study. Clinical feasibility is assessed using structured questionnaires addressing voice and speech, quality of life, breathing, swallowing, olfaction, sleeping, and respiratory symptoms. This is an exploratory, observational study and no specific hypotheses have been formulated.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date April 2014
Est. primary completion date April 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years or older

- has a tracheostomy

- is spontaneously breathing

- has a cuffless tracheostomy tube

- has a tracheostomy tube with inner and outer cannula

- currently uses an HME and/or speaking valve

Exclusion Criteria:

- patient unable to handle or remove the device him/herself when needed, e.g. has decreased level of cognition or reduced mobility of the arms and/or hands

- is mechanically ventilated in any way

- has a tidal volume of less than 100 ml

- is suffering from severe aspiration

- is laryngectomized: the device will block the possibility to exhale if speaking mode is unintentionally activated

- has severe upper airway obstruction, this may cause air trapping

- has thick and copious secretions which might block the device

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TW speaking valve/HME
The TW speaking valve with HME will be used during the day, whereas during sleep patients will use an HME without an automatic speaking valve. Data from TW15 and TW22 will be combined.

Locations

Country Name City State
Netherlands University Medical Center Groningen Groningen

Sponsors (1)

Lead Sponsor Collaborator
Atos Medical AB

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate Patient Experiences Associated With Exposure to the Speaking Valve With a Heat- and Moisture Exchanger (TW) for Tracheotomized Patients Based on Results From Questionnaires. Patients were asked to use either the old TW15 and the TW22 HME device for a week, data combined for the two devices (the device used was recorded). After each week, patients completed a device specific questionnaire (Borg Scale).
After the re-design (ie Updated speaking valve), patients were asked to use the new Speaking Valve for a week and then to complete relevant sections of the same questionnaire. Both at baseline and in the follow-up, patients were asked about their breathing using a Borg scale at a particular moment. This scale has a range from 0-6 where a score close to "0" indicates less breathing problems.
3 weeks including Baseline, week 1, 2 (old device) and week 3 (updated device).
Primary Hours of HME Use Per Day. The mean number of hours of TW use per 24 hours was calculated. Weeks 1 and 2 (Old device, data averaged) and Week 3 (Updated device)
Primary Device Preference Rating. Patients were asked to rate the devices on a scale from 0-10, where "10" indicates the best score and "0" the worst score. The overall mean satisfaction with the speaking valve was rated. Weeks 1 and 2 (Old device, data averaged) and Week 3 (Updated device)
See also
  Status Clinical Trial Phase
Completed NCT02116608 - Treatment of Tracheostomy Granulomas Phase 4
Not yet recruiting NCT06375369 - Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy N/A
Terminated NCT00323986 - Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy Phase 2
Not yet recruiting NCT06236542 - Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety N/A
Completed NCT03955874 - Mechanical Ventilation Discontinuation Practices
Completed NCT04668742 - Efficacy and Safety of the DYNAtraq Device to Prevent Complications in Tracheostomy in Mechanically Ventilated Patients N/A
Recruiting NCT05047432 - Concordance of Methods to Select Tracheostomy Tube Size for Adults in Intensive Care
Recruiting NCT06120790 - Investigation of a 3 oz Water Protocol on Patients With Tracheostomies
Withdrawn NCT05658029 - An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy Phase 1
Active, not recruiting NCT05041894 - Effect of Body Tilting on Diaphragm Excursion and Thickness in the Stroke Patients With Tracheotomy by Ultrasonography
Active, not recruiting NCT02990871 - Efficacy of an Early Rehabilitation on Decannulation Time of Patients With Severe Acquired Brain Injury N/A
Enrolling by invitation NCT06283953 - Boosting Resources for Tracheostomy Care at Home N/A
Not yet recruiting NCT04872881 - Comparison of Effectiveness of Different Airway Management Methods During Percutaneous Tracheostomy Phase 4
Completed NCT02512744 - Reducing Decannulation Time: Limitation of Decannulation Capping Trials (REDECAP) N/A
Recruiting NCT04642703 - Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy
Completed NCT04447638 - Percutaneous Tracheostomy With COVID-19
Completed NCT05434442 - Caregivers Tracheal Aspiration Training N/A
Not yet recruiting NCT06431048 - No DIET Trial: Dogmatic Interruption of Enteral nuTrition N/A
Recruiting NCT02469909 - Comparison Between Immediate and Gradual Decannulation N/A
Completed NCT03512054 - Pilot Study Evaluating the Success (= Safe Decannulation) of a Standardized Tracheotomy Weaning Procedure in Brain-injury's Patients N/A